Targeting Cytokine Signaling as an Innovative Therapeutic Approach for the Prevention of Atherosclerotic Plaque Development

被引：0
|
作者：
Harald Schuett
Bernhard Schieffer
机构：
[1] Hannover Medical School,Clinic for Cardiology and Angiology
来源：
Current Atherosclerosis Reports | 2012年 / 14卷
关键词：
Tocilizumab; Coronary Artery Disease Patient; Innate Immune Defense; Experimental Mouse Model; Infection Susceptibility;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：187 / 189
页数：2
相关论文
共 50 条
  • [31] Targeting metabolic syndrom in chronic disease prevention: development of an innovative, interactive and patient focused program
    Burns, S. L.
    Chan, S.
    Naruki-Van Velzen, M.
    Mcqueen, K.
    Kam, C.
    Graham, A.
    Ignaszewski, A.
    Frohlich, J.
    Bondy, G.
    EUROPEAN HEART JOURNAL, 2009, 30 : 657 - 657
  • [32] Genome-wide cell-specific approach to atherosclerotic plaque rupture identifies the involvement of the adipocytokine signaling pathway
    Lee, K.
    Polvikoski, T.
    Birchall, D.
    Santibanez-Koref, M.
    Mendelow, A. D.
    Keavney, B.
    EUROPEAN HEART JOURNAL, 2006, 27 : 458 - 458
  • [33] Targeting UPR signaling pathway by dasatinib as a promising therapeutic approach in chronic myeloid leukemia
    Buket Ozel
    Sezgi Kipcak
    Cigir Biray Avci
    Maryam Sabour Takanlou
    Leila Sabour Takanlou
    Burcin Tezcanli Kaymaz
    Ilknur Karatekin
    Cumhur Gunduz
    Nur Selvi Gunel
    Medical Oncology, 39
  • [34] Targeting UPR signaling pathway by dasatinib as a promising therapeutic approach in chronic myeloid leukemia
    Ozel, Buket
    Kipcak, Sezgi
    Biray Avci, Cigir
    Sabour Takanlou, Maryam
    Sabour Takanlou, Leila
    Tezcanli Kaymaz, Burcin
    Karatekin, Ilknur
    Gunduz, Cumhur
    Selvi Gunel, Nur
    MEDICAL ONCOLOGY, 2022, 39 (09)
  • [35] Targeting the Bail-driven signaling pathway as a therapeutic approach for breast cancer treatment
    Odubanjo, Oluwatoyin V.
    Tchounwou, Paul B.
    Ogle, Brenda M.
    Noubissi, Felicite K.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (12)
  • [36] In Silico Development of Combinatorial Therapeutic Approaches Targeting Key Signaling Pathways in Metabolic Syndrome
    Maksim Khotimchenko
    Nicholas E. Brunk
    Mark S. Hixon
    Daniel M. Walden
    Hypatia Hou
    Kaushik Chakravarty
    Jyotika Varshney
    Pharmaceutical Research, 2022, 39 : 2937 - 2950
  • [37] In Silico Development of Combinatorial Therapeutic Approaches Targeting Key Signaling Pathways in Metabolic Syndrome
    Khotimchenko, Maksim
    Brunk, Nicholas E.
    Hixon, Mark S.
    Walden, Daniel M.
    Hou, Hypatia
    Chakravarty, Kaushik
    Varshney, Jyotika
    PHARMACEUTICAL RESEARCH, 2022, 39 (11) : 2937 - 2950
  • [38] Development of a Small Peptide-Based Molecular Imaging Probe Targeting LOX-1 for Noninvasive Identification of Atherosclerotic Plaque
    Budge, Loren P.
    Sweeney, Elizabeth E.
    Mohamed, Salma S.
    Lipinski, Michael J.
    Bui, An H.
    Klibanov, Alexander L.
    Kramer, Christopher M.
    Meyer, Craig H.
    Glover, David K.
    Kelly, Kimberly A.
    CIRCULATION, 2010, 122 (21)
  • [39] Therapeutic strategies for targeting the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel disease
    Mitsuyama, Keiichi
    Matsumot, Satoshi
    Masuda, Junya
    Yamasaki, Hiroshi
    Kuwaki, Kotaro
    Takedatsu, Hidetoshi
    Sata, Michio
    ANTICANCER RESEARCH, 2007, 27 (6A) : 3749 - 3756
  • [40] A Computer Simulation Approach to Assessing Therapeutic Intervention Points for the Prevention of Cytokine-Induced Cartilage Breakdown
    Proctor, C. J.
    Macdonald, C.
    Milner, J. M.
    Rowan, A. D.
    Cawston, T. E.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (04) : 979 - 989
12345